I started this Blog after being diagnosed with Prostate Cancer in 2010. It was a way of keeping family and friends informed. It then became a campaigning tool helping to make improvements in hospitals nationally. In 2013 we moved to Johannesburg, setting up our own e-education company. Now we have moved to Bangkok, where we will work and tour the Far East. After surgery 5 years ago my PSA remains at zero, the cancer has gone, and I remain thankful.
We have a round-up of all the action so far from The Men United Arms. And there are so many ways you can get involved we've had to split it into sections! Among them is the first national conference to bring together gay and bisexual men and trans women who have prostate cancer, with people who provide support. Find out more and sign up here.
We hope you like getting this newsletter but, if not, you can unsubscribe at any time.
As EastEnders’ Stan Carter is feeling bleak about his future with advanced prostate cancer, we talk to Louise Crossley-Birch, whose husband, Malcolm, has advanced disease and is dealing with some of the same issues as Stan. Louise talks about Malcolm's treatment, including chemotherapy, which Stan has refused, and managing pain. And while Stan is preoccupied with thoughts of his death, she discusses their feelings about an uncertain future and the prospect of losing Malcolm. Read their story.
For EastEnders' Stan Carter, beating prostate cancer might mean not letting the side effects of treatment, particualry chemotherapy, dominate the last few months of his life. But how many more men will have to make this choice? In her latest blog, Sophie Lutter explores possible future treatments for advanced disease that could change the game. And she asks if we can move forwards by looking back. Read more.
The Scottish Medicines Consortium (SMC) announced last week that they would not be making abiraterone available on the Scottish NHS for men with advanced prostate cancer that no longer responds to hormone therapy, and who haven’t had chemotherapy.
Some men choose not to be treated with chemotherapy, or to delay treatment, and some men are not fit enough to undergo it. This decision effectively denies an alternative treatment to those men and denies a choice to men who would rather delay chemotherapy, but would still benefit from abiraterone. Find out more about this decision.